Skip to content

Dr. DEVOS MD

Active
Private limited companyfounded 200917 years activeSainte-Anne 9, 7880 Flobecq, BelgiumKBO/BCE: BE 0817.960.418
Summary

Dr. DEVOS MD has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€42,497) and a net result of -€4,762. Equity remains stable across the filed fiscal years (±1.6% per year). Its solvency ranks better than 5% of 779 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
2 sites
Size
€2,737total assets 2025
Equity
-€42,497
Loss
-€4,762
Financial health
53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Accounts filed 28 days late0 of 2 deeds read
Why 53Capped at 59: negative equity- Loss of €4,762 (FY 2025)- Negative equity -€42,497+ Size: total assets €2,737+ Sector Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 12% of its sector peers (NACE 86, micro)
Negative equity caps the score at 59. Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency 0=
equity -1552.9% of total assets
Liquidity 50=
short-term debt 291.9% · cash 100.0%
Profitability 0-100
return on assets -174.0%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,979 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.2%▼ -0.1 percentage points vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.3%▲ +0.1 percentage points vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.2%▼ -0.1 percentage points vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026 08-2026: 0.4%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.3%▼ -0.1 percentage points vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 1% on solvency, 20% on liquidity, 1% on profitability and 25% on growth.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €2,737
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Sector Human health activities (NACE 86)
KBO
raises risk · Loss of €4,762 (FY 2025)
NBB · annual accounts
raises risk · Negative equity -€42,497
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€42,497
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
28 days late
2024
111 days late
2023
61 days late
2022
150 days late
2021
61 days late
2020
87 days late
2019
122 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 89 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 1 October (4 of the last 5 filed years within 49 days of that day).
Companies Code · seven months
Position in the running window
08-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Annual accounts filedfiscal year 2024 · full…
  3. Highest result since 2018net €2,618 ▲34.9%

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€42,497 View
  • Caution: Among the weakest 5% on solvencysector median 58.4% · 779 companies -1552.9% View
  • Total assets 20256 fiscal years filed €2,737 View

By topic

Financials

Fiscal year
2025
Total assets
€2,737
Loss
-€4,762
Solvency
-1552.9%
Total assets▼ 34.6%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2017
Next accounts
by 31-07-2027
  1. 30-09-2024Annual accounts filed
  2. 31-12-2023Back to profit
  3. 28-12-2023Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
21-08-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.